SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE)

Cancer Statistics, 2010

Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596 · see citing works

Gene expression profiling predicts clinical outcome of breast cancer

van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · see citing works

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,411 · see citing works

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · see citing works

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,191 · see citing works

Genes that mediate breast cancer metastasis to lung

Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · see citing works

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,848 · see citing works

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,060 · see citing works

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

Bild, A., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D. A. D., Joshi, M.-B., Harpole, D. H., Lancaster, J. M., Berchuck, A., et al. (2005) · Nature · doi:10.1038/nature04296 · Cited by 1,992 · see citing works

Estrogen receptors: how do they signal and what are their targets

Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857 · see citing works

Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription

Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,647 · see citing works

Genome-wide analysis of estrogen receptor binding sites

Carroll, J. S., Meyer, C. A., Song, J. S., Li, W., Geistlinger, T., Eeckhoute, J., Brodsky, A. S., Keeton, E. K., Fertuck, K. C., Hall, G., et al. (2006) · Nature Genetics · doi:10.1038/ng1901 · Cited by 1,368 · see citing works

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,288 · see citing works

The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling

Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,202 · see citing works

Estrogen receptor interaction with estrogen response elements

Klinge, C. M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.14.2905 · Cited by 1,087 · see citing works

Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

Desmedt, C., Piette, F., Loi, S., Wang, Y., Lallemand, F., Haibe‐Kains, B., Viale, G., Delorenzi, M., Zhang, Y., Saghatchian, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2765 · Cited by 970 · see citing works

X chromosomal abnormalities in basal-like human breast cancer

Richardson, A. L., Wang, Z. C., Nicolo, A. D., Lu, X. L., Brown, M. A., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.013 · Cited by 868 · see citing works

Terminal Differentiation of Human Breast Cancer through PPARγ

Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 850 · see citing works

Functional variants of OCTN cation transporter genes are associated with Crohn disease

Peltekova, V. D., Wintle, R. F., Rubin, L. A., Amos, C. I., Huang, Q., Gu, X., Newman, W. G., Oene, M. V., Cescon, D. W., Greenberg, G. R., et al. (2004) · Nature Genetics · doi:10.1038/ng1339 · Cited by 837 · see citing works

Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer

Ivshina, A. V., George, J., Sen'ko, O. V., Mow, B. M. F., Putti, T. C., Smeds, J., Lindahl, T., Yudi Pawitan, Y., Hall, P. N., Nordgren, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4414 · Cited by 751 · see citing works

An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells

Klein‐Hitpaß, L., Schorpp, M., Wagner, U. G., & Ryffel, G. U. (1986) · Cell · doi:10.1016/0092-8674(86)90705-1 · Cited by 720 · see citing works

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

Hess, K. R., Anderson, K., Symmans, W. F., Valero, V., Ibrahim, N. K., Mejia, J. A., Booser, D. J., Theriault, R. L., Buzdar, A. U., Dempsey, P. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6861 · Cited by 720 · see citing works

Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2

Tamai, I., Ohashi, R., Nezu, J., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20378 · Cited by 696 · see citing works

Rapid actions of plasma membrane estrogen receptors

Kelly, M. J., & Levin, E. R. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00377-0 · Cited by 643 · see citing works

Estrogen Signaling Multiple Pathways to Impact Gene Transcription

Marino, M., Galluzzo, P., & Ascenzi, P. (2006) · Current Genomics · doi:10.2174/138920206779315737 · Cited by 618 · see citing works

The role of estrogen in the initiation of breast cancer

Russo, J., & Russo, I. H. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.004 · Cited by 575 · see citing works

Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

Nezu, J., Tamai, I., Oku, A., Ohashi, R., Yabuuchi, H., Hashimoto, N., Nikaido, H., Sai, Y., Koizumi, A., Shoji, Y., et al. (1999) · Nature Genetics · doi:10.1038/5030 · Cited by 553 · see citing works

Disorders of carnitine transport and the carnitine cycle

Longo, N., Amat di San Filippo, C., & Pasquali, M. (2006) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30087 · Cited by 543 · see citing works

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

Saal, L. H., Johansson, P. A., Holm, K., Gruvberger-Saal, S. K., She, Q., Maurer, M. S., Koujak, S., Ferrando, A. A., Malmström, P., Memeo, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702507104 · Cited by 514 · see citing works

Whole-Genome Cartography of Estrogen Receptor α Binding Sites

Lin, C., Vega, V. B., Thomsen, J. S., Zhang, T., Kong, S. L., Xie, M., Chiu, K. P., Lipovich, L., Barnett, D., Stossi, F., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030087 · Cited by 459 · see citing works

Identification of a new brain-specific transcription factor, NURR1

Law, S. W. T., Conneely, O. M., DeMayo, F. J., & O’Malley, B. W. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.12.1491694 · Cited by 399 · see citing works

Estrogen receptor and breast cancer

Sommer, S., & Fuqua, S. A. W. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0389 · Cited by 355 · see citing works

cDNA Sequence, Transport Function, and Genomic Organization of Human OCTN2, a New Member of the Organic Cation Transporter Family

Wu, X., Prasad, P. D., Leibach, F. H., & Ganapathy, V. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8669 · Cited by 340 · see citing works

Estrogen Receptor Alpha in Human Breast Cancer: Occurrence and Significance

Ali, S., & Coombes, R. (2000) · Journal of mammary gland biology and neoplasia · doi:10.1023/a:1009594727358 · Cited by 336 · see citing works

Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen

Hurtado, A., Holmes, K. A., Geistlinger, T., Hutcheson, I. R., Nicholson, R. I., Brown, M. A., Jiang, J., Howat, W., Ali, S., & Carroll, J. S. (2008) · Nature · doi:10.1038/nature07483 · Cited by 319 · see citing works

The role of carnitine in normal and altered fatty acid metabolism

Hoppel, C. L. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00112-4 · Cited by 297 · see citing works

Estrogen receptors: orchestrators of pleiotropic cellular responses

Moggs, J. G., & Orphanides, G. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve185 · Cited by 234 · see citing works

Estrogen Receptor-Mediated Rapid Signaling

Moriarty, K., Kim, K. H., & Bender, J. R. (2006) · Endocrinology · doi:10.1210/en.2006-0729 · Cited by 205 · see citing works

Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy

Shao, W., & Brown, M. A. (2003) · Breast Cancer Research · doi:10.1186/bcr742 · Cited by 201 · see citing works

Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency

Wang, Y., Ye, J., Ganapathy, V., & Longo, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2356 · Cited by 194 · see citing works

Estrogen Induces c-myc Gene Expression via an Upstream Enhancer Activated by the Estrogen Receptor and the AP-1 Transcription Factor

Wang, C., Mayer, J. A., Mazumdar, A., Fertuck, K. C., Kim, H., Brown, M. A., & Brown, P. H. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1037 · Cited by 194 · see citing works

Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle

Campbell, S. E., & Febbraio, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e803 · Cited by 178 · see citing works

Mutations of OCTN2, an Organic Cation/Carnitine Transporter, Lead to Deficient Cellular Carnitine Uptake in Primary Carnitine Deficiency

Tang, N. L. S., Ganapathy, V., Wu, X., Hui, J., Seth, P., Yuen, P. M. P., Fok, T. F., & Hjelm, N. M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.655 · Cited by 153 · see citing works

Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers

Ginestier, C., Cervera, N., Finetti, P., Esteyriès, S., Esterni, B., Adélaı̈de, J., Xerri, L., Viens, P., Jacquemier, J. D., Charafe‐Jauffret, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2339 · Cited by 135 · see citing works

Global Gene Expression Analysis of Estrogen Receptor Transcription Factor Cross Talk in Breast Cancer: Identification of Estrogen-Induced/Activator Protein-1-Dependent Genes

DeNardo, D. G., Kim, H.-T., Hilsenbeck, S. G., Cuba, V. L., Tsimelzon, A. I., & Brown, P. H. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0267 · Cited by 120 · see citing works

Carnitine biosynthesis, metabolism, and functions

Frenkel, R., & McGarry, J. (1980) · Medical Entomology and Zoology · Cited by 119 · see citing works

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

Miller, W. R., Larionov, A. A., Renshaw, L., Anderson, T. J., White, S., Murray, J., Murray, E. L., Hampton, G. M., Walker, J. R., Ho, S., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32820b853a · Cited by 101 · see citing works

NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3

Mages, H. W., Rilke, O., Bravo, R., Senger, G., & Kroczek, R. A. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.11.7877627 · Cited by 97 · see citing works

17beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle

Campbell, S. E., Mehan, K. A., Tunstall, R., Febbraio, M. A., & Cameron‐Smith, D. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310037 · Cited by 86 · see citing works

Membrane-initiated steroid action in breast and prostate cancer

Kampa, M., Pelekanou, V., & Castanas, E. (2007) · Steroids · doi:10.1016/j.steroids.2007.12.009 · Cited by 68 · see citing works

Differential regulation of transcription by the NURR1/NUR77 subfamily of nuclear transcription factors.

Murphy, E. P., Dobson, A. D. W., Keller, C., & Conneely, O. M. (1996) · Europe PMC (PubMed Central) · Cited by 66 · see citing works

Evidence for Linkage of Human Primary Systemic Carnitine Deficiency with D5S436: A Novel Gene Locus on Chromosome 5q

Shoji, Y., Koizumi, A., Kayo, T., Ohata, T., Takahashi, T., Harada, K., & Takada, G. (1998) · The American Journal of Human Genetics · doi:10.1086/301911 · Cited by 55 · see citing works

Age- and Sex-Related Differences of Serum Carnitine in a Japanese Population

Takiyama, N., & Matsumoto, K. (1998) · Journal of the American College of Nutrition · doi:10.1080/07315724.1998.10720458 · Cited by 54 · see citing works

Effect of Lapatinib on the Development of Estrogen Receptor–Negative Mammary Tumors in Mice

Strecker, T. E., Shen, Q., Zhang, Y., Hill, J. L., Li, Y., Wang, C., Kim, H.-T., Gilmer, T. M., Sexton, K. R., Hilsenbeck, S. G., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn436 · Cited by 49 · see citing works

The Role of the Carnitine System in Peroxisomal Fatty Acid Oxidation

Ramsay, R. R. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199907000-00005 · Cited by 47 · see citing works

A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor–Positive Tumors

Yu, K., Ganesan, K., Miller, L. D., & Tan, P. B. O. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1530 · Cited by 45 · see citing works

pS2Gene Expression in HepG2 cells: Complex Regulation through Crosstalk between the Estrogen Receptor α, an Estrogen-Responsive Element, and the Activator Protein 1 Response Element

Barkhem, T., Haldosén, L., Gustafsson, J.-Å., & Nilsson, S. V. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.6.1273 · Cited by 45 · see citing works

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study

Santiago, J. L., Martínez, A., de la Calle, H., Fernández‐Arquero, M., Figueredo, M. A., de la Concha, E. G., & Urcelay, E. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-54 · Cited by 44 · see citing works

The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells

Wang, C., Mayer, J. A., Mazumdar, A., & Brown, P. H. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1775-9 · Cited by 34 · see citing works

Rexinoid-induced Expression of IGFBP-6 Requires RARβ-dependent Permissive Cooperation of Retinoid Receptors and AP-1

Uray, I. P., Shen, Q., Seo, H.-S., Kim, H., Lamph, W. W., Bissonnette, R. P., & Brown, P. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804721200 · Cited by 30 · see citing works

REGULATION OF THE CARNITINE CONCENTRATION IN PLASMA

Borum, P. R. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-267060-2.50016-x · Cited by 27 · see citing works

Regulation of the Intronic Promoter of Rat Estrogen Receptor α Gene, Responsible for Truncated Estrogen Receptor Product-1 Expression

Schausi, D., Tiffoche, C., & Thieulant, M.-L. (2003) · Endocrinology · doi:10.1210/en.2003-0024 · Cited by 10 · see citing works

The SLC22 family with transporters of organic cations, anions and zwitterions

Koepsell, H. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.010 · Cited by 390 · see citing works

Organic Cation Transporters in Health and Disease

Koepsell, H. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015578 · Cited by 293 · see citing works

The Mouse Microbiome Is Required for Sex-Specific Diurnal Rhythms of Gene Expression and Metabolism

Weger, B. D., Gobet, C., Yeung, J., Martin, E., Jimenez, S., Betrisey, B., Foata, F., Berger, B., Balvay, A., Foussier, A., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.023 · Cited by 269 · see citing works

SLC Family Transporters.

Liu, X.-D. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-7647-4_3 · Cited by 78 · see citing works

The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring

Chiaradonna, F., Ricciardiello, F., & Palorini, R. (2018) · Cells · doi:10.3390/cells7060053 · Cited by 169 · see citing works

OCTN Cation Transporters in Health and Disease

Pochini, L., Scalise, M., Galluccio, M., & Indiveri, C. (2013) · Journal of biomolecular screening · doi:10.1177/1087057113493006 · Cited by 99 · see citing works

Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease

Sahoo, S., Aurich, M. K., Jónsson, J. J., & Thiele, I. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00091 · Cited by 103 · see citing works

Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers

Lee, J., Zhao, X.-M., Yoon, I., Lee, J. Y., Kwon, N. H., Wang, Y.-Y., Lee, K.-M., Lee, M.-J., Kim, J., Moon, H., et al. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.25 · Cited by 83 · see citing works

OCTN: A Small Transporter Subfamily with Great Relevance to Human Pathophysiology, Drug Discovery, and Diagnostics

Pochini, L., Galluccio, M., Scalise, M., Console, L., & Indiveri, C. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218812821 · Cited by 83 · see citing works

Carnitine Traffic in Cells. Link With Cancer

Console, L., Scalise, M., Mazza, T., Pochini, L., Galluccio, M., Giangregorio, N., Tonazzi, A., & Indiveri, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.583850 · Cited by 69 · see citing works

SLC22A5 (OCTN2) Carnitine Transporter—Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer

Juraszek, B., & Nałęcz, K. A. (2019) · Molecules · doi:10.3390/molecules25010014 · Cited by 68 · see citing works

L -Carnitine–Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme

Fink, M. A., Paland, H., Herzog, S., Grube, M., Vogelgesang, S., Weitmann, K., Bialke, A., Hoffmann, W. U., Rauch, B. H., Schroeder, H. W. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2380 · Cited by 54 · see citing works

Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5

Juraszek, B., Czarnecka‐Herok, J., & Nałęcz, K. A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15124 · Cited by 54 · see citing works

The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy

Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58 · see citing works

Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis

Sutherland, R., Meeson, A. P., & Lowes, S. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09879-6 · Cited by 54 · see citing works

The role of branched chain amino acids metabolic disorders in tumorigenesis and progression

Wang, J., Wang, W., Zhu, F., & Duan, Q. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113390 · Cited by 47 · see citing works

Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women

Adedokun, B., Du, Z., Gao, G., Ahearn, T. U., Lunetta, K. L., Zirpoli, G., Figueroa, J. D., John, E. M., Bernstein, L., Zheng, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24327-x · Cited by 47 · see citing works

Transcriptional Regulation of Solute Carrier Drug Transporters

Zhou, S., & Shu, Y. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000704 · Cited by 35 · see citing works

Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha

Frietze, S. E., O’Geen, H., Littlepage, L. E., Simion, C., Sweeney, C. A., Farnham, P., & Krig, S. R. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-520 · Cited by 35 · see citing works

Therapeutic Options for Metastatic Breast Cancer

Sambi, M., Qorri, B., Harless, W. W., & Szewczuk, M. R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-20301-6_8 · Cited by 37 · see citing works

Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation

Farahzadi, R., Hejazi, M. S., Molavi, O., Pishgahzadeh, E., Montazersaheb, S., & Jafari, S. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/9328344 · Cited by 36 · see citing works

OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma

Yang, T., Liang, N. N., Zhang, J., Bai, Y., Li, Y., Zhao, Z., Chen, L., Yang, M., Huang, Q., Hu, P., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155628 · Cited by 33 · see citing works

Hierarchical Clustering of Breast Cancer Methylomes Revealed Differentially Methylated and Expressed Breast Cancer Genes

Lin, I., Chen, D.-T., Chang, Y.-F., Lee, Y.-L., Su, C.-H., Cheng, C., Tsai, Y.-C., Ng, S.-C., Chen, H.-T., Lee, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118453 · Cited by 33 · see citing works

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?

Brecht, K., Schäfer, A. M., & zu Schwabedissen, H. E. M. (2020) · Cancers · doi:10.3390/cancers12082263 · Cited by 29 · see citing works

Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue

Otter, M., Csader, S., Keiser, M., & Oswald, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010255 · Cited by 27 · see citing works

Inflammation and Organic Cation Transporters Novel (OCTNs)

Pochini, L., Galluccio, M., Console, L., Scalise, M., Eberini, I., & Indiveri, C. (2024) · Biomolecules · doi:10.3390/biom14040392 · Cited by 25 · see citing works

Novel FOXF1 Deep Intronic Deletion Causes Lethal Lung Developmental Disorder, Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins

Szafrański, P., Yang, Y., Nelson, M. U., Bizzarro, M. J., Morotti, R. A., Langston, C., & Stankiewicz, P. (2013) · Human Mutation · doi:10.1002/humu.22395 · Cited by 23 · see citing works

Estrogen receptor α (ERα) indirectly induces transcription of human renal organic anion transporter 1 (OAT1)

Euteneuer, A. M., Seeger‐Nukpezah, T., Nolte, H., & Henjakovic, M. (2019) · Physiological Reports · doi:10.14814/phy2.14229 · Cited by 18 · see citing works

Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review

Anagnostakis, F., Kokkorakis, M., Markouli, M., & Piperi, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119393 · Cited by 16 · see citing works

Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer

Hussein, S., Khanna, P., Yunus, N., & Gatza, M. L. (2021) · Cancers · doi:10.3390/cancers13194808 · Cited by 15 · see citing works

The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs

Tsume, Y., Bermejo, B. B., & Amidon, G. L. (2014) · Pharmaceuticals · doi:10.3390/ph7020169 · Cited by 14 · see citing works

The Human OCTN Sub-Family: Gene and Protein Structure, Expression, and Regulation

Galluccio, M., Tripicchio, M., & Pochini, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168743 · Cited by 13 · see citing works

Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes

Mei, Z., Liu, J., Bennett, D. A., Seyfried, N., Wingo, A. P., & Wingo, T. S. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70206 · Cited by 11 · see citing works

Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific manner.

Huttunen, J., Tampio, J., Järvinen, J., Montaser, A. B., Markowicz-Piasecka, M., & Huttunen, K. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110833 · Cited by 10 · see citing works

Dysfunction of the carnitine cycle in tumor progression

Wang, X., Yang, C., Huang, C., & Wang, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35961 · Cited by 10 · see citing works

The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of Tyrosine Kinase Inhibitors

Xiu, F.-R., Rausch, M., Gai, Z.-B., Su, S., Wang, S.-J., & Visentin, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032101 · Cited by 9 · see citing works

A Proposed TUSC7/miR-211/Nurr1 ceRNET Might Potentially be Disturbed by a cer-SNP rs2615499 in Breast Cancer

Abdollahzadeh, R., Azarnezhad, A., Paknahad, S., Mansoori, Y., Pirhoushiaran, M., Kanaani, K., Bafandeh, N., Jafari, D., & Tavakkoly‐Bazzaz, J. (2022) · Biochemical Genetics · doi:10.1007/s10528-022-10216-5 · Cited by 9 · see citing works

Estimation of causal effects of genes on complex traits using a Bayesian-network-based framework applied to GWAS data

Yin, L., Feng, Y., Shi, Y., Lau, A., Qiu, J., Sham, P. C., & So, H. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00906-7 · Cited by 8 · see citing works

The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase

Papierniak, A., Lamch, W., Jurewicz, E., & Nałęcz, K. A. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109616 · Cited by 8 · see citing works

Effective Cellular Transport of Ortho-Halogenated Sulfonamide Derivatives of Metformin Is Related to Improved Antiproliferative Activity and Apoptosis Induction in MCF-7 Cells

Markowicz-Piasecka, M., Komeil, I. A., Huttunen, J., Sikora, J., & Huttunen, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072389 · Cited by 8 · see citing works

Dynamic miRNA Landscape Links Mammary Gland Development to the Regulation of Milk Protein Expression in Mice

Wang, W., Zang, X., Liu, Y., Liang, Y., Cai, G., Wu, Z., & Li, Z. (2022) · Animals · doi:10.3390/ani12060727 · Cited by 7 · see citing works

Membrane drug transporters in cancer: From chemoresistance mechanism to therapeutic strategies

Pan, C., & Lee, L. T. O. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189272 · Cited by 6 · see citing works

Carnitine/organic cation transporter 2 (OCTN2) contributes to rat epididymal epithelial cell growth and proliferation

Li, D., Liu, J., Du, W., Liu, H., Xiao, W., Song, X., Fan, Z., Ke, C., Qiangguo, Y., Qin, W., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.057 · Cited by 6 · see citing works

Construction of l -Carnitine-Modified TPGS Micelles to Achieve Oral Delivery of Camptothecin and Targeted Anticancer Effects

Chen, H., Hong, M., Liu, X., Xu, X., Li, J., Li, C., Yue, Q., Cheng, S., & Li, C. (2024) · ACS Applied Polymer Materials · doi:10.1021/acsapm.4c00169 · Cited by 5 · see citing works

A Bayesian network-based framework to uncover the causal effects of genes on complex traits based on GWAS dataPreprint

Yin, L., Feng, Y., Lau, A., Qiu, J., Sham, P. C., & So, H. (2022) · medRxiv · doi:10.1101/2022.12.25.22283943 · Cited by 5 · see citing works

Physiological and Pathophysiological Regulation of Transporters for Organic Cations

Schlatter, E. (2015) · Springer eBooks · doi:10.1007/978-3-319-23793-0_5 · Cited by 4 · see citing works

SREBP1-Dependent Metabolism as a Potential Target for Breast Cancer Risk Reduction

Hajirahimkhan, A., Brown, K. A., Clare, S. E., & Khan, S. A. (2025) · Cancers · doi:10.3390/cancers17101664 · Cited by 3 · see citing works

ORGANIC CATION TRANSPORTERS OF THE SLC22 FAMILY. MOLECULAR DIVERSITY, STRUCTURE, FUNCTION, PARTNERSHIP IN THE FUNCTIONING OF THE INTERORGAN COMMUNICATION SYSTEM OF ANIMALS (A REWIEW)

Смирнов, Л. П. (2018) · Proceedings of the Karelian Research Centre of the Russian Academy of Sciences · doi:10.17076/eb866 · Cited by 2 · see citing works

Tooth loss and adiposity: possible role of carnitine transporter (OCTN1/2) polymorphisms in women but not in men

Meisel, P., Pagels, S., Grube, M., Jedlitschky, G., Völzke, H., & Kocher, T. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03594-w · Cited by 2 · see citing works

Immunization method for multi-pass membrane proteins using highly metastatic cell lines

Satofuka, H., Okabe, Y., Takano, Y., Utsugi, T., Ohtsu, M., & Murakami, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.065 · Cited by 2 · see citing works

Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics

Dinarvand, N., Karimi, F., Azizi, R., Rastaghi, S., Sheikhi, A., & Pourfarzam, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08152-z · Cited by 2 · see citing works

CARINH, an Interferon-Induced LncRNA in Cancer and Inflammation

Gourvest, M., & Solingen, C. V. (2025) · Non-Coding RNA · doi:10.3390/ncrna11060079 · Cited by 1 · see citing works

SLCO and SLC22 Solute Carriers: Establishing Differential Expression Patterns in Human Breast Cancer Cell Lines and Tumour SamplesPreprint

Sutherland, R., Meeson, A. P., & Lowes, S. (2021) · Research Square · doi:10.21203/rs.3.rs-349903/v1 · Cited by 1 · see citing works

Information-theoretic Quantification of High-order Feature Effects in Classification ProblemsPreprint

Lazić, I., Barà, C., Iovino, M., Stramaglia, S., Jakovljevic, N. M., & Faes, L. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5489573 · Cited by 1 · see citing works

Seeking an Important Role on Metabolomics—Effects of β-Estradiol on Lipoprotein Metabolism in Mammary Tumors

Morita, T. (2022) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.22-00098

Information-theoretic quantification of high-order feature effects in classification problems

Lazić, I., Barà, C., Iovino, M., Stramaglia, S., Kasas-Lazetic, K., Jakovljevic, N. M., & Faes, L. (2025) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2025.117724

Lipopeptides from Bacillus Probiotics Can Target Transmembrane Receptors NOX4, EGFR, PDGFR, and OCTN2 Involved in Oxidative Stress and Oncogenesis

Prazdnova, E. V., Amirdzhanov, F. F., Ranjan, A., & Skripnichenko, R. V. (2026) · BioTech · doi:10.3390/biotech15010004

Identification of Potential Therapeutic Targets for Xihuang Pill in Breast Cancer: A Mendelian Randomization and Experimental Study

Tang, Y., Yang, Z., Ye, Z., Su, H., Zhu, R., Meng, X., & Zheng, Q. (2026) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s572244

Lipid metabolism reprogramming: key mechanism of breast cancer endocrine therapy resistance

Sui, Z., Han, X., Liu, S., Tang, Y., Zhang, H., Fan, L., Su, C., & Zhao, W. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1848165

NR4A2: a next-generation drug target orchestrating dynamic gene regulation and protein interactions

Arora, R., Gambhir, S., Bhardwaj, A., & Gupta, P. K. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104837

Abstract 1235: The organic cation transporter SLC22A5 gene is regulated by the cooperative activity of the estrogen receptor and other transcription factors in breast cancer

Wang, C., Mayer, J. A., DeNardo, D. G., & Brown, P. H. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-1235

Study of the activity of Estrogen Response Elements present on Pax‐5 promoter and their potential role on regulating Pax‐5 expression in breast cancer

Faye, M. D., & Ouellette, R. J. (2009) · The FASEB Journal · doi:10.1096/fasebj.23.1_supplement.lb278 · Cited by 1 · see citing works

ESR1-Mediated Regulation of Slc2a4 Gene Expression by Estrogen: Demonstration of a Potential Estrogen Responsive Element (ERE) in the Slc2a4 Gene Promoter

Laurindo, C. P., Gregorio, K. C. R., Freitas, H. S., Bezerra, C. N. A., Okamoto, M. M., Seraphim, P. M., Festuccia, W. T., & Machado, U. F. (2026) · British journal of healthcare and medical research · doi:10.14738/bjhr.1302.20178

SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen‑receptor‑positive breast cancer

Törnroos, R., Tina, E., & Eremo, A. G. (2021) · Oncology Reports · doi:10.3892/or.2021.8228 · Cited by 26 · see citing works

Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer.

Bouras, T., Southey, M. C., Chang, A. C.-M., Reddel, R. R., Willhite, D., Glynne, R. J., Henderson, M. A., Armes, J. E., & Venter, D. J. (2002) · PubMed · Cited by 153 · see citing works